ArticleCancers2024

Improving Cure Rates for Patients with Newly Diagnosed Large B-Cell Lymphomas: Targeted Therapies for High-Risk Pathologic Subgroups as Defined by Clinical Laboratory Testing.

Daniel J LandsburgPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.